Dokumendiregister | Ravimiamet |
Viit | REP-1/1884-1 |
Registreeritud | 23.05.2024 |
Sünkroonitud | 24.05.2024 |
Liik | Sissetulev kiri |
Funktsioon | REP Euroopa Farmakopöaga seotud asjaajamine |
Sari | REP-1 Euroopa Farmakopöa alane kirjavahetus |
Toimik | REP-1/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | European Directorate for the Quality of Medicines & HealthCare |
Saabumis/saatmisviis | European Directorate for the Quality of Medicines & HealthCare |
Vastutaja | Signe Leito (RA, Labor) |
Originaal | Ava uues aknas |
1
Signe Leito
Saatja: [email protected] Saatmisaeg: kolmapäev, 15. mai 2024 11:28 Adressaat: Signe Leito Teema: Proposed deletion of Mycoplasma synoviaevaccine live for chickens 3255 from the WP of Group 15V: EDQM-2024-02021-mail
Please make sure to include in any reply our mail reference: EDQM-2024-02021-mail **************************************************************************** For the attention of NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed deletion of Mycoplasma synoviae vaccine (live) for chickens (3255) from the work programme of Group 15V. In order to have access to the survey, please copy and paste the link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=268823&newtest=Y&lang=en Deadline for replies: 5 June 2024 Thank you. With kind regards On behalf of Catherine LANG Villy NIKOLOVA Administrative Support Assistant European Pharmacopoeia Department EDQM Council of Europe Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://www.edqm.eu/store
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
2
Stay connected with the EDQM
**************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2024-02021-mail
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|---|---|---|---|---|---|
Farmakopöa tööplaani asjus | 23.05.2024 | 1 | REP-1/1884-2 | Väljaminev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |
Farmakopöa tööplaani asjus | 23.05.2024 | 1 | REP-1/1884-2 | Väljaminev kiri | ra | European Directorate for the Quality of Medicines & HealthCare |